{"id":4533,"date":"2024-03-26T13:05:37","date_gmt":"2024-03-26T03:05:37","guid":{"rendered":"\/eu-uk\/?p=4533"},"modified":"2024-04-19T09:43:09","modified_gmt":"2024-04-18T23:43:09","slug":"proactive-interview-with-paul-anderson","status":"publish","type":"post","link":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/","title":{"rendered":"Proactive Interview with Paul Anderson"},"content":{"rendered":"<p>Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company&#8217;s market authorisation study for nerve repair device, Remplir\u2122.<\/p>\n<p>This week, the Company announced the successful completion of the first stage of this study, with all nerve repair surgeries performed without adverse events.<\/p>\n<p>This milestone marks an important step in Orthocell&#8217;s global expansion and pursuit of US market clearance, expected in the early months of 2025.<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/wVbcvwERn4o?si=NRPzDpCkkYH7bqqB\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company&#8217;s market authorisation study for nerve repair device, Remplir\u2122.<\/p>\n","protected":false},"author":2,"featured_media":4550,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-4533","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company&#039;s market authorisation study for nerve repair device, Remplir\u2122.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Orthocell\"\/>\n\t<link rel=\"canonical\" href=\"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Orthocell EU\/UK -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Proactive Interview with Paul Anderson - Orthocell EU\/UK\" \/>\n\t\t<meta property=\"og:description\" content=\"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company&#039;s market authorisation study for nerve repair device, Remplir\u2122.\" \/>\n\t\t<meta property=\"og:url\" content=\"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-03-26T03:05:37+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-04-18T23:43:09+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Proactive Interview with Paul Anderson - Orthocell EU\/UK\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company&#039;s market authorisation study for nerve repair device, Remplir\u2122.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#blogposting\",\"name\":\"Proactive Interview with Paul Anderson - Orthocell EU\\\/UK\",\"headline\":\"Proactive Interview with Paul Anderson\",\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2024\\\/04\\\/Proactive-e1713757337626.png\",\"width\":1000,\"height\":714},\"datePublished\":\"2024-03-26T13:05:37+10:00\",\"dateModified\":\"2024-04-19T09:43:09+10:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#webpage\"},\"articleSection\":\"Media\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/#listItem\",\"name\":\"Media\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/#listItem\",\"position\":2,\"name\":\"Media\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#listItem\",\"name\":\"Proactive Interview with Paul Anderson\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#listItem\",\"position\":3,\"name\":\"Proactive Interview with Paul Anderson\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/media\\\/#listItem\",\"name\":\"Media\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\",\"name\":\"Orthocell EU\\\/UK\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/\",\"name\":\"Orthocell\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Orthocell\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#webpage\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/\",\"name\":\"Proactive Interview with Paul Anderson - Orthocell EU\\\/UK\",\"description\":\"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation study for nerve repair device, Remplir\\u2122.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2024\\\/04\\\/Proactive-e1713757337626.png\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#mainImage\",\"width\":1000,\"height\":714},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2024\\\/03\\\/26\\\/proactive-interview-with-paul-anderson\\\/#mainImage\"},\"datePublished\":\"2024-03-26T13:05:37+10:00\",\"dateModified\":\"2024-04-19T09:43:09+10:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\",\"name\":\"Orthocell EU\\\/UK\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Proactive Interview with Paul Anderson - Orthocell EU\/UK","description":"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation study for nerve repair device, Remplir\u2122.","canonical_url":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#blogposting","name":"Proactive Interview with Paul Anderson - Orthocell EU\/UK","headline":"Proactive Interview with Paul Anderson","author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"publisher":{"@id":"\/eu-uk\/#organization"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2024\/04\/Proactive-e1713757337626.png","width":1000,"height":714},"datePublished":"2024-03-26T13:05:37+10:00","dateModified":"2024-04-19T09:43:09+10:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#webpage"},"isPartOf":{"@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#webpage"},"articleSection":"Media"},{"@type":"BreadcrumbList","@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","position":1,"name":"Home","item":"https:\/\/orthocell.com\/eu-uk","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/media\/#listItem","name":"Media"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/media\/#listItem","position":2,"name":"Media","item":"\/eu-uk\/blog\/category\/media\/","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#listItem","name":"Proactive Interview with Paul Anderson"},"previousItem":{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","name":"Home"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#listItem","position":3,"name":"Proactive Interview with Paul Anderson","previousItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/media\/#listItem","name":"Media"}}]},{"@type":"Organization","@id":"\/eu-uk\/#organization","name":"Orthocell EU\/UK","url":"\/eu-uk\/"},{"@type":"Person","@id":"\/eu-uk\/blog\/author\/hcartres\/#author","url":"\/eu-uk\/blog\/author\/hcartres\/","name":"Orthocell","image":{"@type":"ImageObject","@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"Orthocell"}},{"@type":"WebPage","@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#webpage","url":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/","name":"Proactive Interview with Paul Anderson - Orthocell EU\/UK","description":"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation study for nerve repair device, Remplir\u2122.","inLanguage":"en-GB","isPartOf":{"@id":"\/eu-uk\/#website"},"breadcrumb":{"@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#breadcrumblist"},"author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"creator":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2024\/04\/Proactive-e1713757337626.png","@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#mainImage","width":1000,"height":714},"primaryImageOfPage":{"@id":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/#mainImage"},"datePublished":"2024-03-26T13:05:37+10:00","dateModified":"2024-04-19T09:43:09+10:00"},{"@type":"WebSite","@id":"\/eu-uk\/#website","url":"\/eu-uk\/","name":"Orthocell EU\/UK","inLanguage":"en-GB","publisher":{"@id":"\/eu-uk\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Orthocell EU\/UK -","og:type":"article","og:title":"Proactive Interview with Paul Anderson - Orthocell EU\/UK","og:description":"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation study for nerve repair device, Remplir\u2122.","og:url":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/","article:published_time":"2024-03-26T03:05:37+00:00","article:modified_time":"2024-04-18T23:43:09+00:00","twitter:card":"summary_large_image","twitter:title":"Proactive Interview with Paul Anderson - Orthocell EU\/UK","twitter:description":"Orthocell Managing Director, Paul Anderson, spoke with Jonathan Jackson at Proactive to provide an update on the Company's market authorisation study for nerve repair device, Remplir\u2122."},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/orthocell.com\/eu-uk\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"\/eu-uk\/blog\/category\/media\/\" title=\"Media\">Media<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tProactive Interview with Paul Anderson\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/orthocell.com\/eu-uk"},{"label":"Media","link":"\/eu-uk\/blog\/category\/media\/"},{"label":"Proactive Interview with Paul Anderson","link":"\/eu-uk\/blog\/2024\/03\/26\/proactive-interview-with-paul-anderson\/"}],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4533"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4533\/revisions"}],"predecessor-version":[{"id":4535,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4533\/revisions\/4535"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4550"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4533"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}